Safety and Efficacy of Liposomal Latanoprost in Ocular Hypertension
NCT01987323
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
6
Enrollment
OTHER
Sponsor class
Conditions
Ocular Hypertension
Interventions
DRUG:
Subconjunctival injection of liposomal latanoprost
Sponsor
Singapore Eye Research Institute